Bio-Rad Laboratories, Inc. announced that Christine A. Tsingos has informed the company of her intention to retire as Executive Vice President and Chief Financial Officer effective April 30, 2019. Ms. Tsingos will remain in her current role through April 30 and will assist in the orderly transition to a successor.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
278 USD | -0.79% |
|
-3.79% | -13.89% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.89% | 7.96B | |
-4.72% | 182B | |
-2.83% | 103B | |
-5.01% | 66.94B | |
+15.53% | 46.73B | |
-8.53% | 45.14B | |
+5.82% | 41.57B | |
+17.67% | 30.48B | |
+14.00% | 24.26B | |
-8.08% | 23.58B |
- Stock Market
- Equities
- BIO Stock
- News Bio-Rad Laboratories, Inc.
- Christine Tsingos Plans to Retire as Executive Vice President and Chief Financial Officer of Bio-Rad Laboratories, Inc., Effective April 30, 2019